Published in Br J Pharmacol on September 01, 2002
Molecular action of lidocaine on the voltage sensors of sodium channels. J Gen Physiol (2003) 1.56
High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. Br J Pharmacol (2008) 1.03
Inhibition of cardiac voltage-gated sodium channels by grape polyphenols. Br J Pharmacol (2006) 0.87
An improved model for the binding of lidocaine and structurally related local anaesthetics to fast-inactivated voltage-operated sodium channels, showing evidence of cooperativity. Br J Pharmacol (2003) 0.80
Structural features of phenol derivatives determining potency for activation of chloride currents via alpha(1) homomeric and alpha(1)beta heteromeric glycine receptors. Br J Pharmacol (2005) 0.77
Muscle-Type Nicotinic Receptor Modulation by 2,6-Dimethylaniline, a Molecule Resembling the Hydrophobic Moiety of Lidocaine. Front Mol Neurosci (2016) 0.75
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch (1981) 134.60
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
The influence of potassium and chloride ions on the membrane potential of single muscle fibres. J Physiol (1959) 36.86
Lidocaine block of cardiac sodium channels. J Gen Physiol (1983) 5.13
Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev (1992) 3.65
Primary structure of the adult human skeletal muscle voltage-dependent sodium channel. Ann Neurol (1992) 1.94
Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. EMBO J (1989) 1.91
General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility. J Pharmacol Exp Ther (2001) 1.78
Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels. Biophys J (1996) 1.76
Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels. J Clin Invest (1996) 1.54
K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation. J Physiol (1994) 1.54
Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle. Biophys J (1993) 1.40
Differences in steady-state inactivation between Na channel isoforms affect local anesthetic binding affinity. Biophys J (1997) 1.32
Functional expression and properties of the human skeletal muscle sodium channel. Pflugers Arch (1994) 1.28
Functional consequences of lidocaine binding to slow-inactivated sodium channels. J Gen Physiol (1996) 1.21
Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line. J Physiol (1996) 1.20
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents. J Med Chem (1980) 1.20
Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological profile at recombinant human GABAA receptors. J Med Chem (1998) 1.15
Propofol blocks human skeletal muscle sodium channels in a voltage-dependent manner. Anesth Analg (2001) 1.13
Use-dependent inhibition of Na+ currents by benzocaine homologs. Biophys J (1996) 1.05
Structural requirements of phenol derivatives for direct activation of chloride currents via GABA(A) receptors. Eur J Pharmacol (2001) 1.01
Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels. Eur J Pharmacol (1998) 1.00
Suppression of central nervous system sodium channels by propofol. Anesthesiology (1999) 0.99
Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives. J Pharmacol Exp Ther (1988) 0.99
State-dependent cocaine block of sodium channel isoforms, chimeras, and channels coexpressed with the beta1 subunit. Biophys J (1999) 0.95
Amine blockers of the cytoplasmic mouth of sodium channels: a small structural change can abolish voltage dependence. Biophys J (1994) 0.94
Commentary: A revised view of local anesthetic action: what channel state is really stabilized? J Gen Physiol (1999) 0.91
Succinylcholine metabolite succinic acid alters steady state activation in muscle sodium channels. Anesthesiology (2000) 0.89
Kinetic characterization of rat brain type IIA sodium channel alpha-subunit stably expressed in a somatic cell line. J Physiol (1995) 0.87
Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels. Mol Pharmacol (1993) 0.86
The alpha and gamma subunit-dependent effects of local anesthetics on recombinant GABA(A) receptors. Eur J Pharmacol (2000) 0.84
Cocaine depresses GABAA current of hippocampal neurons. Brain Res (1997) 0.84
Local anesthetics reduce the inhibitory neurotransmitter-induced current in dissociated hippocampal neurons of the rat. Eur J Pharmacol (1995) 0.83
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol (2007) 3.96
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol (2009) 1.56
A mutation in the GABA(A) receptor alpha(1)-subunit is associated with absence epilepsy. Ann Neurol (2006) 1.55
Endotoxin reduces availability of voltage-gated human skeletal muscle sodium channels at depolarized membrane potentials. Crit Care Med (2008) 1.51
Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol (2004) 1.47
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47
Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neurosci (2009) 1.26
ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci (2008) 1.22
Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis. BMC Neurol (2006) 1.21
Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases. Stroke (2011) 1.18
Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol (2008) 1.17
Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol (2009) 1.10
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS One (2012) 1.09
Distribution of GABAA receptor mRNA in the motor cortex of ALS patients. J Neuropathol Exp Neurol (2003) 1.08
Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 1.05
Repetitive transcranial magnetic stimulation for the treatment of chronic pain - a pilot study. Eur Neurol (2002) 1.03
Monitoring drug therapy. Br J Clin Pharmacol (2012) 1.02
Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler (2007) 1.01
Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. Eur J Neurosci (2003) 1.01
Increased intracortical inhibition in middle-aged humans; a study using paired-pulse transcranial magnetic stimulation. Neurosci Lett (2002) 1.01
Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis. Hum Brain Mapp (2011) 1.01
Blood volume measurements using an integrated fiberoptic monitoring system in a porcine septic shock model. Crit Care Med (2006) 1.00
Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav Brain Res (2010) 1.00
Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (2008) 0.99
Intertemporal choice in Parkinson's disease. Mov Disord (2011) 0.99
Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci (2012) 0.99
Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels. Pain (2006) 0.98
Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP. Muscle Nerve (2013) 0.97
Control of kinetic properties of GluR2 flop AMPA-type channels: impact of R/G nuclear editing. Eur J Neurosci (2002) 0.97
Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J Neurol Sci (2009) 0.96
Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? Neurodegener Dis (2012) 0.96
Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixtures. J Neural Transm (Vienna) (2015) 0.95
On emotional conflict: interference resolution of happy and angry prosody reveals valence-specific effects. Cereb Cortex (2009) 0.95
Molecular analysis of the A322D mutation in the GABA receptor alpha-subunit causing juvenile myoclonic epilepsy. Eur J Neurosci (2005) 0.95
Needle acupuncture in chronic poststroke leg spasticity. Arch Phys Med Rehabil (2004) 0.94
Kinetic analysis of the agonistic and blocking properties of pentobarbital on recombinant rat alpha(1)beta(2)gamma(2S) GABA(A) receptor channels. Eur J Pharmacol (2002) 0.94
Topical antiseptics for the treatment of sore throat block voltage-gated neuronal sodium channels in a local anaesthetic-like manner. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.93
Treatment of phantom limb pain with botulinum toxin type A. Pain Med (2009) 0.93
Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock. Crit Care Med (2006) 0.93
Retention and transferability of team resource management skills in anaesthetic emergencies: the long-term impact of a high-fidelity simulation-based course. Eur J Anaesthesiol (2009) 0.93
[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging (2002) 0.92
Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve (2011) 0.92
Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (2010) 0.91
Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph Lateral Scler (2008) 0.91
Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve (2006) 0.90
The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function. Pharmacology (2009) 0.90
Rat embryonic motoneurons in long-term co-culture with Schwann cells--a system to investigate motoneuron diseases on a cellular level in vitro. J Neurosci Methods (2005) 0.89
Perception of emotional speech in Parkinson's disease. Mov Disord (2006) 0.89
Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence. Pharmacogenet Genomics (2005) 0.89
Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathol (2012) 0.89
Changes in resting-state brain networks in writer's cramp. Hum Brain Mapp (2011) 0.89
Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage. Stroke (2013) 0.88
Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis. Mov Disord (2010) 0.88
Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®. J Neural Transm (Vienna) (2014) 0.88
Disturbed egocentric space representation in cervical dystonia. Mov Disord (2005) 0.87
Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J Neuropathol Exp Neurol (2012) 0.87
Structural brain abnormalities in cervical dystonia. BMC Neurosci (2013) 0.86
Cortical processing of swallowing in ALS patients with progressive dysphagia--a magnetoencephalographic study. PLoS One (2011) 0.86
Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Parkinsonism Relat Disord (2008) 0.86
Congenital myasthenic syndrome due to a novel missense mutation in the gene encoding choline acetyltransferase. Neuromuscul Disord (2003) 0.85
Central white matter degeneration in bulbar- and limb-onset amyotrophic lateral sclerosis. J Neurol (2014) 0.85
Educational campaign on stroke in an urban population in Northern Germany: influence on public stroke awareness and knowledge. Int J Stroke (2012) 0.85
Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia. Muscle Nerve (2013) 0.85
Temporal feature perception in cochlear implant users. PLoS One (2012) 0.85
Emotional speech in Parkinson's disease. Mov Disord (2008) 0.85
A transmembrane residue influences the interaction of propofol with the strychnine-sensitive glycine alpha1 and alpha1beta receptor. Anesth Analg (2008) 0.85
Resuscitation from septic shock with capillary leakage: hydroxyethyl starch (130 kd), but not Ringer's solution maintains plasma volume and systemic oxygenation. Shock (2004) 0.85
Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V. J Physiol (2003) 0.84
Changes of emotional prosody in Parkinson's disease. J Neurol Sci (2009) 0.84
Role of mitochondria in kainate-induced fast Ca2+ transients in cultured spinal motor neurons. Cell Calcium (2007) 0.84
Value of quantitative analysis of routine clinical MRI sequences in ALS. Amyotroph Lateral Scler (2011) 0.83
Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. J Neural Transm (Vienna) (2010) 0.83
Disturbed monitoring and response inhibition in patients with Gilles de la Tourette syndrome and co-morbid obsessive compulsive disorder. Behav Neurol (2003) 0.83
Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neurosci (2014) 0.83
Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults. Neurology (2012) 0.83
Decreased brain activation to tongue movements in amyotrophic lateral sclerosis with bulbar involvement but not Kennedy syndrome. J Neurol (2009) 0.83
Amyotrophic lateral sclerosis: who has the lead, the upper or the lower motor neuron? Clin Neurophysiol (2010) 0.83
Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab. J Neuroinflammation (2014) 0.83
The effects of proprioceptive stimulation on cognitive processes in patients after traumatic brain injury. Arch Phys Med Rehabil (2002) 0.83
Therapeutic potential of N-acetyl-glucagon-like peptide-1 in primary motor neuron cultures derived from non-transgenic and SOD1-G93A ALS mice. Cell Mol Neurobiol (2012) 0.83
Movement initiation and inhibition are impaired in amyotrophic lateral sclerosis. Exp Neurol (2010) 0.83
El Escorial or Awaji Criteria in ALS diagnosis, what should we take? Clin Neurophysiol (2011) 0.82
Magnetic resonance imaging in amyotrophic lateral sclerosis. Neurol Res Int (2012) 0.82
Tourette syndrome and obsessive-compulsive disorder: event-related brain potentials show similar mechanisms [correction of mechansims] of frontal inhibition but dissimilar target evaluation processes. Behav Neurol (2003) 0.82
Modulation of glycine receptor function by the synthetic cannabinoid HU210. Pharmacology (2009) 0.82